Guide for Real-World Evidence
Real-world data (RWD) from electronic medical records, insurance claims, and disease registries have expanded what Biotechs can learn about patient outcomes. Turned into real-world evidence (RWE), this is fast becoming a go-to tool for Biotech companies to optimize asset valuation, inform strategy and support regulator and payer decisions.
Parexel Biotech has created this guide to simplify the nomenclature and types of real-world studies.
Related Insights
Article
How RWE can help Biotechs optimize the value of their asset
Apr 5, 2021
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Blog
Integrated evidence planning and RWE: Realizing value throughout the development lifecycle
May 13, 2025
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Video
The science and practice of ethnobridging
May 17, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Playbook
Are you using real-world evidence?
Feb 1, 2023
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Blog
Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions
May 16, 2022
Article
New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle
May 10, 2022
Related Insights
Article
How RWE can help Biotechs optimize the value of their asset
Apr 5, 2021
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Blog
Integrated evidence planning and RWE: Realizing value throughout the development lifecycle
May 13, 2025
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Video
The science and practice of ethnobridging
May 17, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Playbook
Are you using real-world evidence?
Feb 1, 2023
Article
8 things you need to know about eCTDs in China
Jul 1, 2022
Blog
Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions
May 16, 2022
Article
New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle
May 10, 2022